Global Antibodies Contract Manufacturing 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR102421932

Publication Date:

November 8, 2024

Pages:

136

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global Antibodies Contract Manufacturing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Report includes an overview of the development of the Antibodies Contract Manufacturing industry chain, the market status of SME (Monoclonal Antibodies, Antibody Fragments), Large Enterprise (Monoclonal Antibodies, Antibody Fragments), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antibodies Contract Manufacturing.
Regionally, the report analyzes the Antibodies Contract Manufacturing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antibodies Contract Manufacturing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antibodies Contract Manufacturing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antibodies Contract Manufacturing industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Antibody Fragments).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antibodies Contract Manufacturing market.
Regional Analysis: The report involves examining the Antibodies Contract Manufacturing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antibodies Contract Manufacturing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antibodies Contract Manufacturing:
Company Analysis: Report covers individual Antibodies Contract Manufacturing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antibodies Contract Manufacturing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (SME, Large Enterprise).
Technology Analysis: Report covers specific technologies relevant to Antibodies Contract Manufacturing. It assesses the current state, advancements, and potential future developments in Antibodies Contract Manufacturing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antibodies Contract Manufacturing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Antibodies Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Monoclonal Antibodies
Antibody Fragments
Polyclonal Antibodies
麻豆原创 segment by Application
SME
Large Enterprise
麻豆原创 segment by players, this report covers
AMRI
AGC Biologics
Aldevron
Eurofins CDMO
Boehringer Ingelheim BioXcellence
FUJIFILM Diosynth Biotechnologies
Emergent BioSolutions
KBI Biopharma
Lonza
Novasep
Nitto Avecia Pharma Services
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibodies Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibodies Contract Manufacturing, with revenue, gross margin and global market share of Antibodies Contract Manufacturing from 2019 to 2024.
Chapter 3, the Antibodies Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antibodies Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibodies Contract Manufacturing.
Chapter 13, to describe Antibodies Contract Manufacturing research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Antibodies Contract Manufacturing
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Antibodies Contract Manufacturing by Type
1.3.1 Overview: Global Antibodies Contract Manufacturing 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Antibodies Contract Manufacturing Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Monoclonal Antibodies
1.3.4 Antibody Fragments
1.3.5 Polyclonal Antibodies
1.4 Global Antibodies Contract Manufacturing 麻豆原创 by Application
1.4.1 Overview: Global Antibodies Contract Manufacturing 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 SME
1.4.3 Large Enterprise
1.5 Global Antibodies Contract Manufacturing 麻豆原创 Size & Forecast
1.6 Global Antibodies Contract Manufacturing 麻豆原创 Size and Forecast by Region
1.6.1 Global Antibodies Contract Manufacturing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Antibodies Contract Manufacturing 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Antibodies Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Antibodies Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Antibodies Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Antibodies Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Antibodies Contract Manufacturing 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 AMRI
2.1.1 AMRI Details
2.1.2 AMRI Major Business
2.1.3 AMRI Antibodies Contract Manufacturing Product and Solutions
2.1.4 AMRI Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 AMRI Recent Developments and Future Plans
2.2 AGC Biologics
2.2.1 AGC Biologics Details
2.2.2 AGC Biologics Major Business
2.2.3 AGC Biologics Antibodies Contract Manufacturing Product and Solutions
2.2.4 AGC Biologics Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 AGC Biologics Recent Developments and Future Plans
2.3 Aldevron
2.3.1 Aldevron Details
2.3.2 Aldevron Major Business
2.3.3 Aldevron Antibodies Contract Manufacturing Product and Solutions
2.3.4 Aldevron Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Aldevron Recent Developments and Future Plans
2.4 Eurofins CDMO
2.4.1 Eurofins CDMO Details
2.4.2 Eurofins CDMO Major Business
2.4.3 Eurofins CDMO Antibodies Contract Manufacturing Product and Solutions
2.4.4 Eurofins CDMO Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Eurofins CDMO Recent Developments and Future Plans
2.5 Boehringer Ingelheim BioXcellence
2.5.1 Boehringer Ingelheim BioXcellence Details
2.5.2 Boehringer Ingelheim BioXcellence Major Business
2.5.3 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product and Solutions
2.5.4 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
2.6 FUJIFILM Diosynth Biotechnologies
2.6.1 FUJIFILM Diosynth Biotechnologies Details
2.6.2 FUJIFILM Diosynth Biotechnologies Major Business
2.6.3 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product and Solutions
2.6.4 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.7 Emergent BioSolutions
2.7.1 Emergent BioSolutions Details
2.7.2 Emergent BioSolutions Major Business
2.7.3 Emergent BioSolutions Antibodies Contract Manufacturing Product and Solutions
2.7.4 Emergent BioSolutions Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Emergent BioSolutions Recent Developments and Future Plans
2.8 KBI Biopharma
2.8.1 KBI Biopharma Details
2.8.2 KBI Biopharma Major Business
2.8.3 KBI Biopharma Antibodies Contract Manufacturing Product and Solutions
2.8.4 KBI Biopharma Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 KBI Biopharma Recent Developments and Future Plans
2.9 Lonza
2.9.1 Lonza Details
2.9.2 Lonza Major Business
2.9.3 Lonza Antibodies Contract Manufacturing Product and Solutions
2.9.4 Lonza Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Lonza Recent Developments and Future Plans
2.10 Novasep
2.10.1 Novasep Details
2.10.2 Novasep Major Business
2.10.3 Novasep Antibodies Contract Manufacturing Product and Solutions
2.10.4 Novasep Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Novasep Recent Developments and Future Plans
2.11 Nitto Avecia Pharma Services
2.11.1 Nitto Avecia Pharma Services Details
2.11.2 Nitto Avecia Pharma Services Major Business
2.11.3 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product and Solutions
2.11.4 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Nitto Avecia Pharma Services Recent Developments and Future Plans
2.12 Pierre Fabre
2.12.1 Pierre Fabre Details
2.12.2 Pierre Fabre Major Business
2.12.3 Pierre Fabre Antibodies Contract Manufacturing Product and Solutions
2.12.4 Pierre Fabre Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Pierre Fabre Recent Developments and Future Plans
2.13 Samsung BioLogics
2.13.1 Samsung BioLogics Details
2.13.2 Samsung BioLogics Major Business
2.13.3 Samsung BioLogics Antibodies Contract Manufacturing Product and Solutions
2.13.4 Samsung BioLogics Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Samsung BioLogics Recent Developments and Future Plans
2.14 Synthon
2.14.1 Synthon Details
2.14.2 Synthon Major Business
2.14.3 Synthon Antibodies Contract Manufacturing Product and Solutions
2.14.4 Synthon Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Synthon Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Antibodies Contract Manufacturing Product and Solutions
2.15.4 Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Antibodies Contract Manufacturing Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Antibodies Contract Manufacturing by Company Revenue
3.2.2 Top 3 Antibodies Contract Manufacturing Players 麻豆原创 Share in 2023
3.2.3 Top 6 Antibodies Contract Manufacturing Players 麻豆原创 Share in 2023
3.3 Antibodies Contract Manufacturing 麻豆原创: Overall Company Footprint Analysis
3.3.1 Antibodies Contract Manufacturing 麻豆原创: Region Footprint
3.3.2 Antibodies Contract Manufacturing 麻豆原创: Company Product Type Footprint
3.3.3 Antibodies Contract Manufacturing 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Antibodies Contract Manufacturing Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Antibodies Contract Manufacturing 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Antibodies Contract Manufacturing Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Antibodies Contract Manufacturing 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Antibodies Contract Manufacturing Consumption Value by Type (2019-2030)
6.2 North America Antibodies Contract Manufacturing Consumption Value by Application (2019-2030)
6.3 North America Antibodies Contract Manufacturing 麻豆原创 Size by Country
6.3.1 North America Antibodies Contract Manufacturing Consumption Value by Country (2019-2030)
6.3.2 United States Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Antibodies Contract Manufacturing Consumption Value by Type (2019-2030)
7.2 Europe Antibodies Contract Manufacturing Consumption Value by Application (2019-2030)
7.3 Europe Antibodies Contract Manufacturing 麻豆原创 Size by Country
7.3.1 Europe Antibodies Contract Manufacturing Consumption Value by Country (2019-2030)
7.3.2 Germany Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Antibodies Contract Manufacturing 麻豆原创 Size by Region
8.3.1 Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Region (2019-2030)
8.3.2 China Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Antibodies Contract Manufacturing Consumption Value by Type (2019-2030)
9.2 South America Antibodies Contract Manufacturing Consumption Value by Application (2019-2030)
9.3 South America Antibodies Contract Manufacturing 麻豆原创 Size by Country
9.3.1 South America Antibodies Contract Manufacturing Consumption Value by Country (2019-2030)
9.3.2 Brazil Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Antibodies Contract Manufacturing 麻豆原创 Size by Country
10.3.1 Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Country (2019-2030)
10.3.2 Turkey Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Antibodies Contract Manufacturing 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Antibodies Contract Manufacturing 麻豆原创 Drivers
11.2 Antibodies Contract Manufacturing 麻豆原创 Restraints
11.3 Antibodies Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Antibodies Contract Manufacturing Industry Chain
12.2 Antibodies Contract Manufacturing Upstream Analysis
12.3 Antibodies Contract Manufacturing Midstream Analysis
12.4 Antibodies Contract Manufacturing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

AMRI
AGC Biologics
Aldevron
Eurofins CDMO
Boehringer Ingelheim BioXcellence
FUJIFILM Diosynth Biotechnologies
Emergent BioSolutions
KBI Biopharma
Lonza
Novasep
Nitto Avecia Pharma Services
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.